Ponezumab

Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease. Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial. Detailed reports have to be released.